<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00824889</url>
  </required_header>
  <id_info>
    <org_study_id>2008-A00064-51</org_study_id>
    <secondary_id>2008-03</secondary_id>
    <nct_id>NCT00824889</nct_id>
  </id_info>
  <brief_title>Exploratory Study of Natural Killer Cells in Human Skin</brief_title>
  <official_title>Exploratory Study of Natural Killer Cells in Human Skin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Natural Killer (NK) cells play a unique role during innate immune responses as they are able
      to recognize and eliminate, without specific sensitization, tumors, microbe-infected cells as
      well as allogeneic cells.In a first time, we will characterize the tissue distribution, the
      phenotype and the effector functions of NK cells present in the human healthy skin.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Then, we will define whether these parameters are qualitatively/ quantitatively modified in
      the following skin pathologies: a) atopic dermatitis; b) contact dermatitis; c) psoriasis ;
      d) lichen planus ; e) GVH (graft versus host disease) ; (f) melanoma.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">November 2011</completion_date>
  <primary_completion_date type="Actual">November 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>In a first time, we will characterize the tissue distribution, the phenotype and the effector functions of NK cells present in the human healthy skin.</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To determine whether the eventual modifications detected in skin pathologies are correlated to qualitative/ quantitative alterations of NK cell subsets present in the peripheral blood.</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>7</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Atopic Dermatitis</condition>
  <condition>Contact Dermatitis</condition>
  <condition>Psoriasis</condition>
  <condition>Lichen Planus</condition>
  <condition>Graft Versus Host Disease</condition>
  <condition>Melanoma</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Healthy volunteer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>atopic dermatitis patient</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>contact dermatitis patient</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>psoriasis patient</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>lichen planus patient</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>GVH patient</description>
  </arm_group>
  <arm_group>
    <arm_group_label>7</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>melanoma patient</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biopsy and sample of blood</intervention_name>
    <description>Biopsy and sample of blood</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biopsy and sample of blood</intervention_name>
    <description>Biopsy and sample of blood</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biopsy and sample of blood</intervention_name>
    <description>Biopsy and sample of blood</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biopsy and sample of blood</intervention_name>
    <description>Biopsy and sample of blood</description>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biopsy and sample of blood</intervention_name>
    <description>Biopsy and sample of blood</description>
    <arm_group_label>5</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biopsy and sample of blood</intervention_name>
    <description>Biopsy and sample of blood</description>
    <arm_group_label>6</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biopsy and sample of blood</intervention_name>
    <description>Biopsy and sample of blood</description>
    <arm_group_label>7</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age â‰¥ 18 years.

          -  Consent obtained after healthy donor or patient information.

          -  Patients suffering from one of the following diseases: a) atopic dermatitis ; b)
             contact dermatitis; c) psoriasis ; d) lichen planus ; e) GVH ; f) melanoma.

        Exclusion Criteria:

          -  Age below 18,

          -  pregnant or breastfeeding women,

          -  persons under guardianship, persons without social security, prisoners, persons
             hospitalized without consent on the basis of French laws L. 3212-1 et L. 3213-1.
             Patients affected by HIV infection, AIDS, Hepatitis A, B or C infection.

          -  Neutropenia &lt;1000/mm3.

          -  Thrombopenia &lt;50 000/mm3.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Caroline Gaudy-Marqueste, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique des Hopitaux de Marseille</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service de Dermatologie- Hopital Sainte Marguerite</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 13, 2009</study_first_submitted>
  <study_first_submitted_qc>January 16, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 19, 2009</study_first_posted>
  <last_update_submitted>August 28, 2014</last_update_submitted>
  <last_update_submitted_qc>August 28, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 29, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psoriasis</mesh_term>
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Dermatitis, Atopic</mesh_term>
    <mesh_term>Eczema</mesh_term>
    <mesh_term>Graft vs Host Disease</mesh_term>
    <mesh_term>Lichen Planus</mesh_term>
    <mesh_term>Dermatitis, Contact</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

